ReviewJournal of clinical medicine2025

Personalizing IL-23 Inhibitor Therapy in IBD: Current Evidence and Future Directions in Therapeutic Drug Monitoring and Dose Optimization.

Alessandro Pedicelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.